Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-09

FDA Approved: SCOPOLAMINE — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved a generic scopolamine product from Amneal Pharmaceuticals NY LLC under an original ANDA (ANDA218384).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SCOPOLAMINE (SCOPOLAMINE)

Snippet

ORIG AP for SCOPOLAMINE (SCOPOLAMINE)